Intersect ENT®, Inc., a company dedicated to transforming care for patients with ear, nose and throat conditions, has gained Centers … continue reading “CMS Approval for SINUVA® Sinus Implant”
“The high-resolution mode combined with small field of view is ideal for temporal bone imaging”
Real-time navigation for ENT specialists in the O.R. and surgeon office
Procedures may now be performed on patients as young as 18. New data on local anesthesia also recognized
Patients who benefitted from Latera experienced continued symptom relief after the implant had absorbed
New device reduces risk of cross contamination and unintentional patient burns from damaged insulation
Newly presented prospective multi-center study yields significant reduction in nasal obstruction symptoms
Newly cleared minimally invasive device for lateral cartilage support in patients with nasal valve collapse, a major cause of nasal obstruction
Clinical study conducted on revision subjects supports expanded indication for patients with previously surgically altered tissue
System works for people with significant mixed hearing loss
Comparative study will assess improvement in patient outcomes from avoidance of steroid bolus
“I’ve been a surgeon since 1960 and this technology is one of the most significant operating room advances I’ve seen in decades”
Two new devices will expand portfolio of low-pressure, self-expanding dilation devices to treat frontal and sphenoid sinusitis, in addition to maxillary disease.
Lumenis sees its dual CO2 laser technology featured at this week’s Combined Otolaryngology Spring Meetings (COSM) in Boston
SinuSys Corporation is to commence a new clinical trial of its proprietary drug-eluting spacer, infused with steroids for use following functional endoscopic sinus surgery (FESS)
MED-EL USA has announced U.S. FDA approval of its new SYNCHRONY cochlear implant, the first time such a device has been approved for use with 3.0 Tesla MRI without the surgical removal of the internal magnet.